Table 1. Clinical characteristics of the diabetic patients and non-diabetic controls.
| Group | Age (years) | Sex (M/F) | Diabetes duration (years) | FBG (mmol/l) | PBG (mmol/l) | HbA1c (%) |
|---|---|---|---|---|---|---|
|
Samples used in dot immunobinding assay | ||||||
| CTL |
59.0±9.4 |
8/7 |
- |
- |
- |
- |
| DR |
61.3±7.6 |
7/8 |
8.0±6.8 |
9.1±2.4 |
12.4±3.7 |
10.0±2.4 |
| DNR |
61.1±8.4 |
8/7 |
9.0±4.5 |
7.7±3.4 |
11.8±4.2 |
9.9±2.6 |
|
Samples used in 1D gel analysis | ||||||
| CTL |
54.4±12.0 |
3/2 |
- |
- |
- |
- |
| DR |
64.5±5.0 |
2/2 |
9.8±9.4 |
8.2±1.5 |
10.4±1.7 |
8.0±2.6 |
| DNR |
68.5±5.0 |
1/2 |
8.5±0.7 |
7.9±1.0 |
10.4±1.0 |
7.0±0.9 |
|
Samples used in 2D gel analysis | ||||||
| CTL |
57.3±8.6 |
15/15 |
- |
- |
- |
- |
| DR |
59.1±10.6 |
15/15 |
11.0±6.1 |
9.4±2.8 |
14.1±5.5 |
10.0±2.3 |
| DNR | 57.3±11.2 | 15/15 | 5.9±4.6* | 9.7±3.7 | 15.6±6.8 | 9.8±2.8 |
In the table, CTL: non-diabetic controls; DR: type 2 diabetics with retinopathy; DNR: type 2 diabetics without retinopathy; FBG: fast blood glucose; PBG: postprandial blood glucose; HbA1c: glycosylated hemoglobin. Data were expressed as mean±standard deviation. The asterisk indicates a p<0.01.